BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Argus Health

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,866,590

« Back to Dashboard

Summary for Patent: 5,866,590

Title: Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
Abstract:The present invention provides a new stable pharmaceutical composition containing tiagabine hydrochloride as active ingredient.
Inventor(s): Svensson; J.o slashed.rgen Ryhl (Frederikssund, DK), Nygaard; Lars (Valby, DK), Andersen; Tina Meinertz (Hoersholm, DK), Weibel; Helle (Hilleroed, DK), Hjorth; Thyge Borup (Farum, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:08/945,585
Patent Claim Types:
see list of patent claims
Composition; Process; Formulation;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,866,590

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark0523/95May 05, 1995
PCT Information
PCT FiledApril 29, 1996PCT Application Number:PCT/DK96/00192
PCT Publication Date:November 07, 1996PCT Publication Number: WO96/34606

International Patent Family for Patent: 5,866,590

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China1092959► Subscribe
China1183721► Subscribe
Czech Republic9703388► Subscribe
Czech Republic292256► Subscribe
Germany69618586► Subscribe
Denmark0830132► Subscribe
Canada2220019► Subscribe
Egypt23781► Subscribe
Spain2171669► Subscribe
European Patent Office0830132► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Farmers Insurance
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: